Currently,research on N^(6)-methyladenine(m^(6)A)is extensive in the field of oncology,while studies involving m^(6)A and skin diseases remain relatively limited.Based on existing reports,we searched PubMed and Web of...Currently,research on N^(6)-methyladenine(m^(6)A)is extensive in the field of oncology,while studies involving m^(6)A and skin diseases remain relatively limited.Based on existing reports,we searched PubMed and Web of Science for literature related to m^(6)A and dermatological conditions.Analysis of citation counts and journal impact factors revealed a significant upward trend in the volume of m^(6)A-related research.Term frequency analysis of titles and abstracts indicated that studies mainly focus on skin tumors and inflammatory or immune-related skin diseases,particularly melanoma,psoriasis,and skin development.Transcriptomic data from the Gene Expression Omnibus(GEO)were analyzed,revealing differential expression of m^(6)A-related genes in 4 types of skin tumors(including squamous cell carcinoma and basal cell carcinoma)as well as in inflammatory skin diseases such as psoriasis and atopic dermatitis,and potential mechanisms of action were also explored.Findings suggest that m^(6)A modifications exhibit heterogeneity between neoplastic and nonneoplastic skin diseases.However,the regulatory mechanisms of m^(6)A dynamic modifications on key genes involved in dermatological disorders remain unclear and warrant further investigation.展开更多
目的:低风险微小乳头状甲状腺癌(papillary thyroid carcinoma,PTC)的检出增加与过度诊断和治疗有关。N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)修饰导致的微RNA(microRNAs,miRNA)失调在肿瘤转移和进展中发挥重要作用。然而,m^(6)...目的:低风险微小乳头状甲状腺癌(papillary thyroid carcinoma,PTC)的检出增加与过度诊断和治疗有关。N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)修饰导致的微RNA(microRNAs,miRNA)失调在肿瘤转移和进展中发挥重要作用。然而,m^(6)A靶向miRNAs在PTC中的功能仍不清楚。本研究旨在探究m^(6)A-miR-139-5p在PTC中的表达调控机制,明确其与PTC转移的关联,并评估其作为PTC转移诊断生物标志物的潜力,为PTC的精准诊断和治疗提供实验依据。方法:通过癌症基因组图谱(The Cancer Genome Atlas,TCGA)和GSE130512队列筛选与PTC转移相关的候选靶向m^(6)A-miRNA分子。收集13例PTC转移患者和18例非转移患者的临床标本,检测m^(6)A-miR-139-5p的表达水平,分析其与转移的相关性。通过实验探究脂肪质量和肥胖相关蛋白(fat mass and obesity-associated protein,FTO)对pri-miR-139甲基化水平及加工过程的影响,明确其对miR-139-5p表达的调控作用。在TPC-1细胞中,通过四甲基偶氮唑盐(methyl thiazolyl tetrazolium,MTT)实验检测miR-139-5p过表达对FTO过表达介导的细胞增殖的影响。通过细胞侵袭实验验证miR-139-5p对PTC细胞侵袭能力的作用,并探究其是否通过靶向ZEB1/E-钙黏蛋白轴发挥功能。结果:通过比较TCGA和GSE130512队列,发现血清循环m^(6)A-miR-139-5p可作为检测PTC转移的生物指标。对13例转移和18例非转移临床标本的检测表明,FTO通过降低其甲基化水平抑制pri-miR-139的加工,导致miR-139-5p在PTC中表达失调(P<0.05)。在TPC-1细胞中,MTT实验显示miR-139-5p过表达可部分逆转FTO过表达介导的细胞增殖(P<0.05)。此外,miR-139-5p通过靶向ZEB1/E-钙黏蛋白轴抑制PTC细胞的侵袭能力,而FTO过表达可部分削弱这种抑制效应。结论:血清循环miR-139-5p可作为评估PTC转移的潜在标志物,FTO通过调控pri-miR-139的m^(6)A修饰影响miR-139-5的表达及功能,但其临床价值需进一步验证。展开更多
N6-甲基腺嘌呤(N6-methyladenosine,m6A)是真核生物信使RNA(Messenger RNA,m RNA)上含量最多的化学修饰之一。类似于DNA和组蛋白化学修饰,m6A修饰也同样是动态可逆的,可在时间和空间上被甲基转移酶和去甲基酶调控。哺乳动物体内m6A甲基...N6-甲基腺嘌呤(N6-methyladenosine,m6A)是真核生物信使RNA(Messenger RNA,m RNA)上含量最多的化学修饰之一。类似于DNA和组蛋白化学修饰,m6A修饰也同样是动态可逆的,可在时间和空间上被甲基转移酶和去甲基酶调控。哺乳动物体内m6A甲基转移酶复合物中有一部分成分已被解析,主要有METTL3(Methyltransferase-like protein 3)、METTL14(Methyltransferase-like protein 14)和WTAP(Wilms tumor 1-associating protein)。m6A去甲基酶肥胖蛋白FTO(Fat mass and obesity associated protein)和ALKBH5(Alk B homolog 5)依赖α-酮戊二酸(α-Ketoglutaric acid,α-KG)和Fe(Ⅱ)对m6A进行氧化去甲基化反应。m6A在生物体内由m6A结合蛋白识别,并介导其行使功能。目前发现的m6A结合蛋白有YTH结构域蛋白YTHDF1(YTH domain-containing family protein 1)、YTHDF2(YTH domain-containing family protein 2)、YTHDC1(YTH domain-containing protein1)和核内HNRNPA2B1(Heterogeneous nuclear ribonucleoproteins A2B1)。本文综述了m6A的分布和相关蛋白介导的m6A功能研究,以期全面理解m6A这一RNA表观遗传新修饰在生命进程中的重要调控作用。展开更多
基金supported by the National Natural Science Foundation,China(82103704).
文摘Currently,research on N^(6)-methyladenine(m^(6)A)is extensive in the field of oncology,while studies involving m^(6)A and skin diseases remain relatively limited.Based on existing reports,we searched PubMed and Web of Science for literature related to m^(6)A and dermatological conditions.Analysis of citation counts and journal impact factors revealed a significant upward trend in the volume of m^(6)A-related research.Term frequency analysis of titles and abstracts indicated that studies mainly focus on skin tumors and inflammatory or immune-related skin diseases,particularly melanoma,psoriasis,and skin development.Transcriptomic data from the Gene Expression Omnibus(GEO)were analyzed,revealing differential expression of m^(6)A-related genes in 4 types of skin tumors(including squamous cell carcinoma and basal cell carcinoma)as well as in inflammatory skin diseases such as psoriasis and atopic dermatitis,and potential mechanisms of action were also explored.Findings suggest that m^(6)A modifications exhibit heterogeneity between neoplastic and nonneoplastic skin diseases.However,the regulatory mechanisms of m^(6)A dynamic modifications on key genes involved in dermatological disorders remain unclear and warrant further investigation.
文摘目的:低风险微小乳头状甲状腺癌(papillary thyroid carcinoma,PTC)的检出增加与过度诊断和治疗有关。N^(6)-甲基腺苷(N^(6)-methyladenosine,m^(6)A)修饰导致的微RNA(microRNAs,miRNA)失调在肿瘤转移和进展中发挥重要作用。然而,m^(6)A靶向miRNAs在PTC中的功能仍不清楚。本研究旨在探究m^(6)A-miR-139-5p在PTC中的表达调控机制,明确其与PTC转移的关联,并评估其作为PTC转移诊断生物标志物的潜力,为PTC的精准诊断和治疗提供实验依据。方法:通过癌症基因组图谱(The Cancer Genome Atlas,TCGA)和GSE130512队列筛选与PTC转移相关的候选靶向m^(6)A-miRNA分子。收集13例PTC转移患者和18例非转移患者的临床标本,检测m^(6)A-miR-139-5p的表达水平,分析其与转移的相关性。通过实验探究脂肪质量和肥胖相关蛋白(fat mass and obesity-associated protein,FTO)对pri-miR-139甲基化水平及加工过程的影响,明确其对miR-139-5p表达的调控作用。在TPC-1细胞中,通过四甲基偶氮唑盐(methyl thiazolyl tetrazolium,MTT)实验检测miR-139-5p过表达对FTO过表达介导的细胞增殖的影响。通过细胞侵袭实验验证miR-139-5p对PTC细胞侵袭能力的作用,并探究其是否通过靶向ZEB1/E-钙黏蛋白轴发挥功能。结果:通过比较TCGA和GSE130512队列,发现血清循环m^(6)A-miR-139-5p可作为检测PTC转移的生物指标。对13例转移和18例非转移临床标本的检测表明,FTO通过降低其甲基化水平抑制pri-miR-139的加工,导致miR-139-5p在PTC中表达失调(P<0.05)。在TPC-1细胞中,MTT实验显示miR-139-5p过表达可部分逆转FTO过表达介导的细胞增殖(P<0.05)。此外,miR-139-5p通过靶向ZEB1/E-钙黏蛋白轴抑制PTC细胞的侵袭能力,而FTO过表达可部分削弱这种抑制效应。结论:血清循环miR-139-5p可作为评估PTC转移的潜在标志物,FTO通过调控pri-miR-139的m^(6)A修饰影响miR-139-5的表达及功能,但其临床价值需进一步验证。
文摘N6-甲基腺嘌呤(N6-methyladenosine,m6A)是真核生物信使RNA(Messenger RNA,m RNA)上含量最多的化学修饰之一。类似于DNA和组蛋白化学修饰,m6A修饰也同样是动态可逆的,可在时间和空间上被甲基转移酶和去甲基酶调控。哺乳动物体内m6A甲基转移酶复合物中有一部分成分已被解析,主要有METTL3(Methyltransferase-like protein 3)、METTL14(Methyltransferase-like protein 14)和WTAP(Wilms tumor 1-associating protein)。m6A去甲基酶肥胖蛋白FTO(Fat mass and obesity associated protein)和ALKBH5(Alk B homolog 5)依赖α-酮戊二酸(α-Ketoglutaric acid,α-KG)和Fe(Ⅱ)对m6A进行氧化去甲基化反应。m6A在生物体内由m6A结合蛋白识别,并介导其行使功能。目前发现的m6A结合蛋白有YTH结构域蛋白YTHDF1(YTH domain-containing family protein 1)、YTHDF2(YTH domain-containing family protein 2)、YTHDC1(YTH domain-containing protein1)和核内HNRNPA2B1(Heterogeneous nuclear ribonucleoproteins A2B1)。本文综述了m6A的分布和相关蛋白介导的m6A功能研究,以期全面理解m6A这一RNA表观遗传新修饰在生命进程中的重要调控作用。
